A citation-based method for searching scientific literature

Bram Verstockt, Sare Verstockt, Jonas Dehairs, Vera Ballet, Helene Blevi, Willem-Jan Wollants, Christine Breynaert, Gert Van Assche, Séverine Vermeire, Marc Ferrante. EBioMedicine 2019
Times Cited: 59







List of co-cited articles
714 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
Nathaniel R West, Ahmed N Hegazy, Benjamin M J Owens, Samuel J Bullers, Bryan Linggi, Sofia Buonocore, Margherita Coccia, Dieter Görtz, Sébastien This, Krista Stockenhuber,[...]. Nat Med 2017
313
61

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD.
Renaud Gaujoux, Elina Starosvetsky, Naama Maimon, Francesco Vallania, Haggai Bar-Yoseph, Sigal Pressman, Roni Weisshof, Idan Goren, Keren Rabinowitz, Matti Waterman,[...]. Gut 2019
88
44

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.
I Arijs, K Li, G Toedter, R Quintens, L Van Lommel, K Van Steen, P Leemans, G De Hertogh, K Lemaire, M Ferrante,[...]. Gut 2009
248
33

TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?
Bram Verstockt, Sare Verstockt, Helene Blevi, Isabelle Cleynen, Magali de Bruyn, Gert Van Assche, Séverine Vermeire, Marc Ferrante. Gut 2019
28
67

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.
Subra Kugathasan, Lee A Denson, Thomas D Walters, Mi-Ok Kim, Urko M Marigorta, Melanie Schirmer, Kajari Mondal, Chunyan Liu, Anne Griffiths, Joshua D Noe,[...]. Lancet 2017
301
30

A blood-based prognostic biomarker in IBD.
Daniele Biasci, James C Lee, Nurulamin M Noor, Diana R Pombal, Monica Hou, Nina Lewis, Tariq Ahmad, Ailsa Hart, Miles Parkes, Eoin F McKinney,[...]. Gut 2019
71
25

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Nicholas A Kennedy, Graham A Heap, Harry D Green, Benjamin Hamilton, Claire Bewshea, Gareth J Walker, Amanda Thomas, Rachel Nice, Mandy H Perry, Sonia Bouri,[...]. Lancet Gastroenterol Hepatol 2019
225
25

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
Aleksejs Sazonovs, Nicholas A Kennedy, Loukas Moutsianas, Graham A Heap, Daniel L Rice, Mark Reppell, Claire M Bewshea, Neil Chanchlani, Gareth J Walker, Mandy H Perry,[...]. Gastroenterology 2020
115
23

Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease.
Bram Verstockt, Sare Verstockt, Brecht Creyns, Sophie Tops, Gert Van Assche, Ann Gils, Jan L Ceuppens, Séverine Vermeire, Marc Ferrante, Christine Breynaert. Aliment Pharmacol Ther 2019
32
40

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
Luke Jostins, Stephan Ripke, Rinse K Weersma, Richard H Duerr, Dermot P McGovern, Ken Y Hui, James C Lee, L Philip Schumm, Yashoda Sharma, Carl A Anderson,[...]. Nature 2012
22

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.
Gaik W Tew, Jason A Hackney, Deena Gibbons, Christopher A Lamb, Diana Luca, Jackson G Egen, Lauri Diehl, Jeff Eastham Anderson, Severine Vermeire, John C Mansfield,[...]. Gastroenterology 2016
94
22

Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease.
Ingrid Arijs, Roel Quintens, Leentje Van Lommel, Kristel Van Steen, Gert De Hertogh, Katleen Lemaire, Anica Schraenen, Clémentine Perrier, Gert Van Assche, Séverine Vermeire,[...]. Inflamm Bowel Dis 2010
118
22

Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy.
Jerome C Martin, Christie Chang, Gilles Boschetti, Ryan Ungaro, Mamta Giri, John A Grout, Kyle Gettler, Ling-Shiang Chuang, Shikha Nayar, Alexander J Greenstein,[...]. Cell 2019
197
22

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease.
Raja Atreya, Helmut Neumann, Clemens Neufert, Maximilian J Waldner, Ulrike Billmeier, Yurdagül Zopf, Marcus Willma, Christine App, Tino Münster, Hermann Kessler,[...]. Nat Med 2014
235
20

Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn's Disease.
Grant E Barber, Vijay Yajnik, Hamed Khalili, Cosmas Giallourakis, John Garber, Ramnik Xavier, Ashwin N Ananthakrishnan. Am J Gastroenterol 2016
52
23

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukas, Filip Baert, Tomas Vaňásek, Ahmet Danalioglu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne,[...]. Lancet 2017
398
20

Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases.
Ashwin N Ananthakrishnan, Chengwei Luo, Vijay Yajnik, Hamed Khalili, John J Garber, Betsy W Stevens, Thomas Cleland, Ramnik J Xavier. Cell Host Microbe 2017
165
20

PRedicting Outcomes For Crohn's dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial.
Miles Parkes, Nurulamin M Noor, Francis Dowling, Harvey Leung, Simon Bond, Lynne Whitehead, Sara Upponi, Paul Kinnon, Andrew P Sandham, Paul A Lyons,[...]. BMJ Open 2018
24
45

Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease.
James C Lee, Daniele Biasci, Rebecca Roberts, Richard B Gearry, John C Mansfield, Tariq Ahmad, Natalie J Prescott, Jack Satsangi, David C Wilson, Luke Jostins,[...]. Nat Genet 2017
132
18

Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis.
Shannon E Telesco, Carrie Brodmerkel, Hongyan Zhang, Lilianne Lee-Lian Kim, Jewel Johanns, Abhijit Mazumder, Katherine Li, Frédéric Baribaud, Mark Curran, Richard Strauss,[...]. Gastroenterology 2018
32
31

Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis.
James C Lee, Paul A Lyons, Eoin F McKinney, John M Sowerby, Edward J Carr, Francesca Bredin, Hannah M Rickman, Huzefa Ratlamwala, Alexander Hatton, Tim F Rayner,[...]. J Clin Invest 2011
190
16

Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
Heike Schmitt, Ulrike Billmeier, Walburga Dieterich, Timo Rath, Sophia Sonnewald, Stephen Reid, Simon Hirschmann, Kai Hildner, Maximilian J Waldner, Jonas Mudter,[...]. Gut 2019
68
16

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
L Peyrin-Biroulet, W Sandborn, B E Sands, W Reinisch, W Bemelman, R V Bryant, G D'Haens, I Dotan, M Dubinsky, B Feagan,[...]. Am J Gastroenterol 2015
981
16

Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
Konrad Aden, Ateequr Rehman, Silvio Waschina, Wei-Hung Pan, Alesia Walker, Marianna Lucio, Alejandro Mena Nunez, Richa Bharti, Johannes Zimmerman, Johannes Bethge,[...]. Gastroenterology 2019
95
16

Ulcerative colitis.
Ryan Ungaro, Saurabh Mehandru, Patrick B Allen, Laurent Peyrin-Biroulet, Jean-Frédéric Colombel. Lancet 2017
16

Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.
Isabelle Cleynen, Gabrielle Boucher, Luke Jostins, L Philip Schumm, Sebastian Zeissig, Tariq Ahmad, Vibeke Andersen, Jane M Andrews, Vito Annese, Stephan Brand,[...]. Lancet 2016
392
15

Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease.
Marla C Dubinsky, Ling Mei, Madison Friedman, Tanvi Dhere, Talin Haritunians, Hakon Hakonarson, Cecilia Kim, Joseph Glessner, Stephan R Targan, Dermot P McGovern,[...]. Inflamm Bowel Dis 2010
98
15

Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients.
Matthew K Doherty, Tao Ding, Charlie Koumpouras, Shannon E Telesco, Calixte Monast, Anuk Das, Carrie Brodmerkel, Patrick D Schloss. mBio 2018
55
16

Infliximab for induction and maintenance therapy for ulcerative colitis.
Paul Rutgeerts, William J Sandborn, Brian G Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B Hanauer, Gary R Lichtenstein,[...]. N Engl J Med 2005
15

Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.
Jason Lloyd-Price, Cesar Arze, Ashwin N Ananthakrishnan, Melanie Schirmer, Julian Avila-Pacheco, Tiffany W Poon, Elizabeth Andrews, Nadim J Ajami, Kevin S Bonham, Colin J Brislawn,[...]. Nature 2019
667
15

Crohn's disease.
Joana Torres, Saurabh Mehandru, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet. Lancet 2017
744
15

Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study.
Inger Camilla Solberg, Morten H Vatn, Ole Høie, Njaal Stray, Jostein Sauar, Jørgen Jahnsen, Bjørn Moum, Idar Lygren. Clin Gastroenterol Hepatol 2007
479
15

A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's Disease.
Thomas Billiet, Konstantinos Papamichael, Magali de Bruyn, Bram Verstockt, Isabelle Cleynen, Fred Princen, Sharat Singh, Marc Ferrante, Gert Van Assche, Severine Vermeire. J Crohns Colitis 2015
33
24

Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
T Hlavaty, M Pierik, L Henckaerts, M Ferrante, S Joossens, N van Schuerbeek, M Noman, P Rutgeerts, S Vermeire. Aliment Pharmacol Ther 2005
133
13

Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.
Gareth J Walker, James W Harrison, Graham A Heap, Michiel D Voskuil, Vibeke Andersen, Carl A Anderson, Ashwin N Ananthakrishnan, Jeffrey C Barrett, Laurent Beaugerie, Claire M Bewshea,[...]. JAMA 2019
73
13

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.
Jimmy Z Liu, Suzanne van Sommeren, Hailiang Huang, Siew C Ng, Rudi Alberts, Atsushi Takahashi, Stephan Ripke, James C Lee, Luke Jostins, Tejas Shah,[...]. Nat Genet 2015
13

Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases.
S Bek, J V Nielsen, A B Bojesen, A Franke, S Bank, U Vogel, V Andersen. Aliment Pharmacol Ther 2016
52
15

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial.
Séverine Vermeire, Sharon O'Byrne, Mary Keir, Marna Williams, Timothy T Lu, John C Mansfield, Christopher A Lamb, Brian G Feagan, Julian Panes, Azucena Salas,[...]. Lancet 2014
303
13

Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response.
Yael Haberman, Rebekah Karns, Phillip J Dexheimer, Melanie Schirmer, Judith Somekh, Ingrid Jurickova, Tzipi Braun, Elizabeth Novak, Laura Bauman, Margaret H Collins,[...]. Nat Commun 2019
97
13

HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.
Graham A Heap, Michael N Weedon, Claire M Bewshea, Abhey Singh, Mian Chen, Jack B Satchwell, Julian P Vivian, Kenji So, Patrick C Dubois, Jane M Andrews,[...]. Nat Genet 2014
123
13

The global burden of IBD: from 2015 to 2025.
Gilaad G Kaplan. Nat Rev Gastroenterol Hepatol 2015
888
13

Vedolizumab as induction and maintenance therapy for Crohn's disease.
William J Sandborn, Brian G Feagan, Paul Rutgeerts, Stephen Hanauer, Jean-Frédéric Colombel, Bruce E Sands, Milan Lukas, Richard N Fedorak, Scott Lee, Brian Bressler,[...]. N Engl J Med 2013
13

Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Brian G Feagan, Paul Rutgeerts, Bruce E Sands, Stephen Hanauer, Jean-Frédéric Colombel, William J Sandborn, Gert Van Assche, Jeffrey Axler, Hyo-Jong Kim, Silvio Danese,[...]. N Engl J Med 2013
13

Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study.
Bruce E Sands, Jingjing Chen, Brian G Feagan, Mark Penney, William A Rees, Silvio Danese, Peter D R Higgins, Paul Newbold, Raffaella Faggioni, Kaushik Patra,[...]. Gastroenterology 2017
145
13


Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
Geert D'Haens, Filip Baert, Gert van Assche, Philip Caenepeel, Philippe Vergauwe, Hans Tuynman, Martine De Vos, Sander van Deventer, Larry Stitt, Allan Donner,[...]. Lancet 2008
905
13

Predictors of Crohn's disease.
Laurent Beaugerie, Philippe Seksik, Isabelle Nion-Larmurier, Jean-Pierre Gendre, Jacques Cosnes. Gastroenterology 2006
612
13

Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.
Niels Vande Casteele, Marc Ferrante, Gert Van Assche, Vera Ballet, Griet Compernolle, Kristel Van Steen, Steven Simoens, Paul Rutgeerts, Ann Gils, Séverine Vermeire. Gastroenterology 2015
555
13

A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia.
Suk-Kyun Yang, Myunghee Hong, Jiwon Baek, Hyunchul Choi, Wanting Zhao, Yusun Jung, Talin Haritunians, Byong Duk Ye, Kyung-Jo Kim, Sang Hyoung Park,[...]. Nat Genet 2014
293
11

NOD2/CARD15 does not influence response to infliximab in Crohn's disease.
Severine Vermeire, Edouard Louis, Paul Rutgeerts, Martine De Vos, Andre Van Gossum, Jacques Belaiche, Paul Pescatore, Rene Fiasse, Paul Pelckmans, Robert Vlietinck,[...]. Gastroenterology 2002
175
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.